<DOC>
	<DOC>NCT01485770</DOC>
	<brief_summary>This is a study to evaluate the safety and effectiveness of ADX-N05 compared to placebo in the treatment of excessive daytime sleepiness in adults with narcolepsy.</brief_summary>
	<brief_title>A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<criteria>Diagnosis of narcolepsy Good general health Willing and able to comply with the study design and schedule and other requirements If female, pregnant or lactating Customary bedtime later than midnight History of significant medical condition, behavioral or psychiatric disorder (including suicidal ideation), or surgical history Any other clinically relevant medical, behavioral or psychiatric disorder other than narcolepsy that is associated with excessive sleepiness History of significant cardiovascular disease Body mass index &gt;34 Excessive caffeine use &gt; 600 mg/day of caffeine or &gt; 6 cups of coffee/day History of alcohol or drug abuse within the past two years Nicotine dependence that has an affect on sleep</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>